Department of Clinical Chemistry
University of Turku

Back to the main page of the Department of Clinical Chemistry

Julkaisut 1999 / Publications in 1999

Väitöskirja / Dissertation

  1. Saraste, A.:  Apoptosis and the Heart.  Annales Universitatis Turkuensis Ser D, Tom 380. 100 p, 1999.

Väitöskirjojen myyntijakelu: Turun yliopiston kirjasto, 20500 TURKU
puh. 02-6336170, fax 02-6335050, telex: 62163 Tyk FI

Distributor of the Dissertations: Turku University Library, FIN-20500 TURKU
tel. +358-2-6336170, fax +358-2-6335050, telex: 62163 Tyk FI

 

Muut julkaisut / Other publications

  1. Ahokoski O, Irjala K, Huhtala S, Salminen E, Shceinin H, Huupponen R: A double-blind study of MPV-2213ad, a novel aromatase inhibitor, in healthy male subjects. Eur J Clin Pharmacol 55:27-34, 1999. [C]
  2. Ahokoski O, *Virtanen A, Huupponen R, Scheinin H, Salminen E, Kairisto V, Irjala K: Mihin tahtiin hyrräävät miehen hormonit? Duodecim 115:2114-2115, 1999. [c]
  3. Ahokoski O, *Virtanen A, Kairisto V, Scheinin H, Huupponen R, Irjala K: Biological day-to-day variation and reference change limits of serum cortisol and aldosterone in healthy young men on unrestricted diets. Clin Chem 45:1097-1099, 1999. [C]
  4. *Donohoe GG, *Salomäki A, *Lehtimäki T, Pulkki K, Kairisto V: Rapid identification of apolipoprotein E genotypes by multiplex-ARMS PCR and capillary gel electrophoresis. Clin Chem 45:143-146, 1999. [C]
  5. Forsström J: Health on the Net - laadunvarmistusta lääketieteellisiin tietopalveluihin. Suomen Lääkärilehti 54:689-691, 1999. [c]
  6. Forsström J: Lääkärin oikeuksien anominen toisesta EU-maasta. Lääkärin EU-opas. Suomen lääkäriliitto 3/1999, 64 sivua, s. 19-21, 1999. [i]
  7. Forsström J: Miten edistää korkeatasoisten lääketieteen tietopalveluiden tarjontaa tietoverkossa? Tiedosta ja Tiedon tutkimuksesta. Suomen Akatemian Tiedon Tutkimusohjelman raportteja 2/1999, Eero Pantzar (toim.), Tampereen yliopisto, 295 sivua, s. 261-268, 1999. [d]
  8. Forsström J: Telelääketiede - kehitystä markkinoiden ehdoilla. Erikoislääkäri 9:82-83, 1999. [i]
  9. Forsström J: Towards Evaluation and Certification of Telematics Services for Health, Key recommendations. Turun yliopisto, 64 sivua, 1999. [b]
  10. Forsström JJ, *Rigby M: Considerations on the quality of medical software and information services. International Journal of Medical Informatics 56:1-3, s. 169-176, 1999. [C]
  11. Forsström J, Takala T, Kailajärvi M, Grönroos P, Irjala K: A computerized system for notifying of drug effects on laboratory tests. Proceedings of "Computers in Medicine 5". Lodz, Poland, 22.-26.9. Published by Polish Society of Medical Informatics, s. 171-175, 1999. [D]
  12. Grenman S, Remes K, Inki P, Itälä M, Kauppila M, Pelliniemi T-T, Rajamäki A, Rantanen V, Salmi T, Vuento M, Salmi T: Kokemukset 10 ensimmäisen munasarjasyöpäpotilaan suuriannoksisesta solunsalpaajahoidosta Turussa. Suomen Lääkäril 28:3359-3364, 1999. [c]
  13. Grönroos JM, Grönroos P: Leucocyte count and C-reactive protein in the diagnosis of accute appendicitis. Br J Surg 86:501-504, 1999. [C]
  14. Grönroos JM, Grönroos P: A fertile-aged woman with right lower abdominal pain but unelevated leukocyte count and C-reactive protein. Acute appendicitis is very unlikely. Langenbeck’s Arch Surg 384:437-440, 1999. [C]
  15. *Haapamäki MM, Grönroos JM, Nurmi H, Irjala K, Alanen KA, Nevalainen TJ: Phospholipase A2 in serum and colonic mucosa in ulcerative colitis. Scand J Clin Lab Invest 59:279-288, 1999. [C]
  16. Heinänen K, Näntö-Salonen K, Komu M, Erkintalo M, Alanen M, Heinonen OJ, Pulkki K, Nikoskelainen E, Sipilä I, Simell O: Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithemia. Eur J Clin Invest 29:1060-1065, 1999. [C]
  17. Heinänen K, Näntö-Salonen K, Komu M, Erkintalo M, Heinonen OJ, Pulkki K, Valtonen M, Nikoskelainen E, Alanen A, Simell O: Muscle creatinine phosphate in gyrate atrophy of the choroid and retina with hyperornithinemia- clues to pathogenesis. Eur J Clin Invest 29:426-431, 1999. [C]
  18. Helin E, Salmi AA, Vanharanta R, Vainionpää R: Measles Virus Replication in Cells of Myelomonocytic Lineage Is Dependent on Cellular Differentetion Stage. Virology 253:35-42, 1999. [C]
  19. Hämäläinen MM, *Eskola JU, Hellman J, Pulkki K: Major interference from leukocytes in reverse transcription-PCR identified as neurotoxin ribonuclease from eosinophils: detection of residual chronic myelogenous leukemia from cell lysates by use of an eosinophil-depleted cell preparation. Clin Chem 45:465-471, 1999. [C]
  20. Isoherranen K, Punnonen K, Jansen C, Uotila P: Ultraviolet irradiation induces cyclooxygenase-2 expression in keratinocytes. Brit J Dermatol 140:1017-1022, 1999. [C]
  21. Isoherranen K, Sauroja I, Jansen C, Punnonen K: UV irradiation induces downregulation of bcl-2 expression in vitro and in vivo. Ardh Dermatol Res, 1999. [C]
  22. Kailajärvi M, Forsström JJ, Grönroos P, Takala T, Irjala K, *Tryding N: Online individual reminders of drug effects in clinical chemistry using a new knowledge base. Clin Chem Lab Med 37, Special supplement: S67, 1999. [D]
  23. Kairisto V: Yhteispohjoismainen viitearvoprojekti. KliinLab 16:4-6, 1999. [e]
  24. Kairisto V: Dissemination of information about the project. In: Dominiczak MH, Näntö V (eds): Joint European Project: Development of Academic Laboratory Medicine s. 125-127. University of Glasgow Computer Publishing Unit (ISBN 1 899333 16 9), 1999. [D]
  25. Kauppila M, Irjala K, Koskinen P, Pulkki K, Sonninen P, Viikari J, Remes K: Bone mineral density after allogeneic bone marrow transplantation. Bone Marrow Transpl 24:885-889, 1999. [C]
  26. Kauppila M, Koskinen P, Pulkki K, Sonninen P, Remes K, Irjala K, Viikari J: Interferon-a treatment decreases serum cross-linked C-terminal telopeptide of type I collagen in haematological diseases. Clin Lab Haematol 21, 1999. [C]
  27. Kivimäki P, Holopainen I, Heinonen OJ, Kairisto V, Pulkki K: Katsaus: Valproaattilääkityksen aineenvaihdunnalliset vaikutukset. KliinLab 16:, 1999. [f]
  28. *Knekt P, *Reunanen A, *Marniemi J, Leino A, *Aromaa A: Low vitamin E status is a potential risk factor for insulin-dependent diabetes mellitus. J Intern Med 245:99-102, 1999. [C]
  29. Koskinen PJ, *Nuutinen HMJ, Laaksonen H, Klossner JA, Irjala KMA, Kalimo H, Viikari JSA: Importance of storing emergency serum samples for uncovering murder with insulin. Forensic Sci Int 105:61-66, 1999. [C]
  30. *Kouri T, *Anttinen J, *Icén A, *Ikäheimo R, Irjala K, *Kontiainen S, *Koskimies O, *Lipponen P, *Penttilä I, *Siitonen A, *Siukola A (toim.): Suositus virtsan perustutkimuksia ja bakteeriviljelyä varten. Moodin erillisjulkaisu 7, 50 sivua, 1999. [i]
  31. *van Kuilenburg AB, *Vreken P, *Abeling NG, *Bakker HD, *Meinsma R, *Van Lenthe H, *De Abreu RA, *Smeitink JA, *Kayseril H, *Apak MY, *Christensen E, Holopainen I, Pulkki K, *Riva D, *Botteon G, *Holme E, *Tulinius M, *Kleyer WJ, *Beemer FA, *Duran M, *Niezen-Koning KE, *Smit GPA, *Jacobs C, *Moog U, *Spaapen LJM, *van Gennip AH: Genotype and phenotype in patients with dihydropyrimidine deficiency. Human Genetics 104:1-9, 1999. [C]
  32. *Lehtonen-Veromaa M, Möttönen T, Irjala K, *Kärkkäinen M, *Lamberg-Allardt C, *Hakola P, Viikari J: Vitamin D intake is low and hypovitaminosis D common in healthy 9- to 15-year-old Finnish girls. Eur J Clin Nutr 53:746-751, 1999. [C]
  33. Leino A: Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx analyzer. Clin Chem 45:569-571, 1999. [C]
  34. Leino A, Irjala K: Viitearvot eurooppalaisten suositusten mukaisille ALAT-, ASAT- ja GT-määrityksille. Suomen Lääkärilehti 54:2371-2374, 1999. [c]
  35. Leino A, *Katajamäki T: Triage Cardiac System myoglobiinin, CK-MB massan ja troponiini I:n samanaikainen määritys kokoveri- tai plasmanäytteestä. KliinLab 6:114-116, 1999. [i]
  36. Leino L, Hurttia H: A potential role of an intracellular signaling defect in neutrophil functional abnormalities and promotion of tissue damage in patients with localized juvenile periodontitis. Clin Chem Lab Med 37:215-222, 1999. [C]
  37. Leino L, Saarinen K, Kivistö K, Koulu L, Jansen CT, Punnonen K: Systemic suppression of human peripheral blood phagocytic leukocytes after whole-body UVB irradiation. J Leukoc Biol 65:573-582, 1999. [C]
  38. *Lund V, Kentala E, Scheinin H, Klossner J, Koskinen P, Jalonen J: Effect of hyperbaric conditions on plasma stress hormone levels and endothelin-1. Undersea Hyperbar Med 26:87-92, 1999. [C]
  39. Lundbom NMI, Manner T, Komu M, Peltola O, Leino KA, Kirvelä OA: Barbiturate Anesthesia and Brain Proton Spectroscopy. Am J Neuroradiol 20:1543-1546, 1999. [C]
  40. Luotolahti M, Hänninen KP, Saraste M, Porela P, Peltonen JM, Pulkki K, Hartiala J, Voipio-Pulkki LM: Is routine echocardiography useful in patients hospitalized for chest pain? Evidence of areal myocardial dysfunction detected only by echocardiography. Clin Physiol 19:467-474, 1999. [C]
  41. *Luukkaa V, Rouru J, Ahokoski O, Scheinin H, Irjala K, Huupponen R: Acute inhibition of oestrogen biosynthesis does not affect serum leptin level in young men. Eur J Endocrinol, in press. [C]
  42. Mäkinen M, Rautava P, Forsström J: Euroopan unioni terveydenhuoltopalvelujen markkina-alueena. Suomen Lääkärilehti 54:4139-4143, 1999. [c]
  43. Näntö V, Juva K, Kairisto V, Pulkki K: Clinical chemistry in the University of Turku. In: Dominiczak MH, Näntö V (eds): Joint European Project: Development of Academic Laboratory Medicine s 52-56. University of Glasgow Computer Publishing Unit (ISBN 1 899333 16 9), 1999. [D]
  44. Näntö-Salonen K, Koskinen P, Sonninen P, Toppari J: Suppression of GH secretion in pituitary gigantism by continuous subcutaneous octreotide infusion in a pubertal boy. Acta Paediatr 88:29-33, 1999. [C]
  45. Penttilä T-L, Koskinen P, Penttilä T-A, Anttila L, Irjala K: Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome. Fertil Steril 71:457-461, 1999. [C]
  46. Perttilä J, Salo M, Ovaska J, Grönroos J, Lavonius M, Katila A, Lähteenmäki M, Pulkki K: Immune response after laparoscopic or conventional Nissen fundoplication. Eur J Surg 165:21-28, 1999. [C]
  47. Polo-Kantola P, Erkkola R, Irjala K, Helenius H, *Pullinen S, Polo O: Climacteric symptoms and sleep quality. Obstet Gynecol 2:219-224, 1999. [C]
  48. Polo-Kantola P, Erkkola R, Irjala K, *Pullinen S, *Virtanen I, Polo O: Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril 71:873-880, 1999. [C]
  49. Porela P, Helenius H, Pulkki K, Voipio-Pulkki L-M: Epidemiological classification of acute myocardial infarction: time for a change? Eur Heart J 20:1459-1464, 1999.[C]
  50. Porela P, *Hänninen KP, Vuorenmaa T, Arstila M, Pulkki K, Bredbacka Å, Antila KJ, Jalonen J, Helenius H, Voipio-Pulkki L-M: Computer-assisted electrocardiography in structured diagnosis of acute myocardial infarction. Scand Cardiovasc J 33:89-96, 1999. [C]
  51. Porela P, Luotolahti M, Helenius H, Pulkki K, Voipio-Pulkki L-M: Automated ECG injury scores to estimate myocardial injury size during the course of acute myocardial infarction. Am J Cardiology 83:949-952, 1999. [C]
  52. *Portin R, Polo-Kantola P, Polo O, *Koskinen T, *Revonsuo A, Irjala K, Erkkola R: Serum estrogen level, attention, memory and other cognitive functions in middle-aged women. Climacteric 2:115-123, 1999. [C]
  53. Punnonen K, Rajamäki A: Evaluation of iron status of Finnish blood donors using serum transferrin receptor. Transfusion Medicine 9:131-134, 1999. [C]
  54. Rajamäki A: Sisäinen laadunohjaus. Moodi 3:117, 1999. [e]
  55. Rajamäki A: Alkukokemuksia luuydinmorfologian ulkoisesta laaduntarkkailusta. Moodi 3:118-119, 1999. [e]
  56. Rajamäki A: Perusverenkuvatutkimuksen vakiointi ja sisäinen laadunohjaus. Moodi 3:127-130, 1999. [e]
  57. Rawlins M, Gullichsen E, Kuttila K, Peltola O, Niinikoski J: Central Hemodynamic Changes in Experimental Muscle Crush Injury in Pigs. Eur Surg Res 31:9-18, 1999. [C]
  58. *Ruokonen E, *Nousiainen T, Pulkki K, *Takala J: Procalcitonin in neutropenic fever. Eur J Clin Microbiol Infect Dis 18:283-285, 1999. [C]
  59. Räty R, Koskinen P, Alanen A, Irjala K, *Matinlauri I, Ekblad U: Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 19:122-127, 1999. [C]
  60. Rönnemaa E, Rönnemaa T, *Utriainen T, Raitakari M, Laine H, Takala T, Pitkänen O-P, Kirvelä O, Knuuti J, Nuutila P: Decreased blood flow but unaltered insulin sensitivity of glucose uptake in skeletal muscle of chronic smokers. Metabolism 48:239-244, 1999. [C]
  61. *Saaresranta T, Polo-Kantola P, Irjala K, Helenius H, Polo O: Respiratory insufficiency in postmenopausal women. Sustained improvement of gas exchange with short-term medroxyprogesterone acetate. Chest 115:1581-1587, 1999. [C]
  62. Saario R, Kotilainen P, Pulkki K: LED-potilaan toistuvat meningiitit. Duodecim 115:397-400, 1999. [C]
  63. Salo P, Viikari J, Hämäläinen M, Lapinleimu H, Routi T, Rönnemaa T, *Seppänen R, Jokinen E, Välimäki I, Simell O: Serum cholesterol ester fatty acids in 7- and 13-month-old children in a prospective randomized trial of low-saturated fat, low-cholesterol diet: The STRIP baby project. Acta Paediatrica 88:505-512, 1999. [C]
  64. Salo P, Viikari J, Rask-Nissilä L, Hämäläinen M, Rönnemaa T, *Seppänen R, Simell O: Effect of low-saturated fat, low-cholesterol dietary intervention on fatty acid compositions in serum lipid fractions in 5-year-old children. The STRIP project. Eur J Clin Nutr 53:927-932, 1999. [C]
  65. Saraste A, Pulkki K, Kallajoki M, *Heikkilä P, *Laine P, *Mattila S, *Nieminen MS, Parvinen M, Voipio-Pulkki L-M: Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29:381-386, 1999. [C]
  66. Scheinin H, Helminen A, Huhtala S, Grönroos P, Bosch JA, Kuusela T, Tahvanainen K, Kanto J, Kaila T: Spectral analysis of heart rate variability as a quantitative measure of parasympatholytic effect – integrated pharmacokinetics and pharmacodynamics of three anticholinergic drugs. Ther Drug Monit 21:141-151, 1999. [C]
  67. Suominen P, Punnonen K, Rajamäki A, *Majuri R, *Hänninen V, Irjala K: Automated immunoturbidimetric method for measuring transferrin receptor. Clin Chem 45:1302-1305, 1999. [C]
  68. Toikka JO, Ahotupa M, Viikari JSA, *Niinikoski H, *Taskinen M-R, Irjala K, Hartiala JJ, Raitakari OT: Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis 147:133-138, 1999. [C]
  69. Turunen P, Forsström J, Tähkäpää J: Visions of health care information systems in Finland by the year 2007. At the point of intersection between different cultures. Turku Centre for Computer Science, TUCS, General Publication No 16, June 1999. Christer Carlsson (ed.), 214 pages. 201-213. [c]
  70. Vanto T, *Juntunen-Backman K, Kalimo K, *Klemola T, Koivikko A, Koskinen P, *Syvänen P, Valovirta E, *Varjonen E: The patch test, skin prick test, and serum milk-specific IgE as diagnostic tools in cow's milk allergy in infants. Allergy 54:837-842, 1999. [C]
  71. *Vasankari T, *Lehtonen-Veromaa M, Möttönen T, Ahotupa M, Irjala K, Heinonen O, Leino A, Viikari J: Reduced mildly oxidized LDL in young female athletes. Atherosclerosis, 1999. [C]
  72. *Vuorimaa T, *Vasankari T, Mattila K, Heinonen O, *Häkkinen K, *Rusko H: Serum hormone and myocellular protein recovery after intermittent runs at the velocity associated with VO2max. Eur J Appl Physiol 1999. [C]
  73. Yang B, Kalimo KO, *Mattila LM, *Kallio SE, Katajisto JK, *Peltola OJ, Kallio HP: Effects of dietary supplementation with sea buckthorn (Hippophaë rhamnoides) seed and pulp oils on atopic dermatitis. J Nutr Biochem 10:622-630, 1999. [C]